tiprankstipranks
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
Canadian Market

Rapid Dose Therapeutics Corp (DOSE) Income Statement

Compare
6 Followers

Rapid Dose Therapeutics Corp Income Statement

Last quarter (Q3 2024), Rapid Dose Therapeutics Corp's total revenue was C$501.69K, an increase of 114.57% from the same quarter last year. In Q3, Rapid Dose Therapeutics Corp's net income was C$-1.36M. See Rapid Dose Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
C$ 1.02MC$ 718.30KC$ 1.75MC$ 262.81KC$ 101.50K
Gross Profit
C$ 563.41KC$ 372.40KC$ 1.34MC$ 207.45KC$ 37.34K
Operating Expenses
C$ 4.21MC$ 3.92MC$ 5.65MC$ 2.33MC$ 7.54M
Depreciation and Amortization
C$ 620.31KC$ 627.44KC$ 765.81KC$ 675.47KC$ 484.06K
EBITDA
C$ -3.02MC$ -2.92MC$ -7.59MC$ -987.23KC$ -7.37M
Operating Income
C$ -3.74MC$ -3.54MC$ -4.30MC$ -2.13MC$ -7.51M
Other Income/Expenses
C$ -567.72KC$ -266.25KC$ -4.19MC$ -170.60KC$ -459.31K
Pretax Income
C$ -4.31MC$ -3.81MC$ -8.49MC$ -2.30MC$ -7.96M
Net Income
C$ -4.31MC$ -3.81MC$ -12.55MC$ -2.44MC$ -8.16M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.04C$ -0.04C$ -0.13C$ -0.03C$ -0.11
Diluted EPS
C$ -0.04C$ -0.04C$ -0.13C$ -0.03C$ -0.11
Weighted Average Shares Outstanding
104.96M 103.42M 100.22M 77.79M 76.09M
Weighted Average Shares Outstanding (Diluted)
104.96M 103.42M 100.22M 77.79M 76.09M
Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis